These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 991829)

  • 1. Decreased pancreatic somatostatin (SRIF) concentration in spontaneously diabetic mice.
    Patel YC; Orci L; Bankier A; Cameron DP
    Endocrinology; 1976 Nov; 99(5):1415-8. PubMed ID: 991829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic somatostatin contents in spontaneously diabetic KK and non-obese diabetic (NOD) mice.
    Matsushima Y; Makino H; Kanatsuka A; Osegawa M; Kumagai A; Nishimura M; Tochino Y; Makino S
    Horm Metab Res; 1982 Jun; 14(6):292-8. PubMed ID: 6126426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in pancreatic somatostatin content in spontaneously diabetic mice, as determined by radioimmunoassay and immunohistochemical methods.
    Makino H; Matsushima Y; Kanatsuka A; Yamamoto M; Kumagai A; Nishimura M
    Endocrinology; 1979 Jan; 104(1):243-7. PubMed ID: 376284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal relationship of tissue somatostatin-like immunoreactivity to metabolic changes in genetically obese and diabetic mice.
    Berelowitz M; Coleman DL; Frohman LA
    Diabetes; 1980 Sep; 29(9):717-23. PubMed ID: 6108273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic polypeptide and other pancreatic hormones in spontaneously diabetic BB/W rats.
    Tomita T; Doull V; Fredrickson D; Pollock G
    Pancreas; 1990 Nov; 5(6):658-67. PubMed ID: 1980735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin: widespread abnormality in tissues of spontaneously diabetic mice.
    Patel YC; Cameron DP; Stefan Y; Malaisse-Lagae F; Orci L
    Science; 1977 Dec; 198(4320):930-1. PubMed ID: 337488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin in the pancreas and hypothalamus of obese mice.
    Dolais-Kitabgi J; Le Marchand-Brustel Y; Freychet P
    Diabetologia; 1979 Oct; 17(4):257-61. PubMed ID: 387502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic time-course studies of the spontaneously diabetic BB Wistar rat. II. Insulin-, glucagon-, and somatostatin-reactive cells in the pancreas.
    Tannenbaum GS; Colle E; Wanamaker L; Gurd W; Goldman H; Seemayer TA
    Endocrinology; 1981 Dec; 109(6):1880-7. PubMed ID: 6118255
    [No Abstract]   [Full Text] [Related]  

  • 9. Pancreatic insulin, glucagon and somatostatin concentrations in rats with islet cell tumors induced by streptozotocin.
    Yoshino G; Utsumi M; Kazumi T; Makimura H; Ishihara K; Kobayashi N; Terashi K; Morita S; Baba S
    Endocrinol Jpn; 1980 Oct; 27(5):561-5. PubMed ID: 6113133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin, glucagon and somatostatin content of the non-obese diabetic (NOD) mouse pancreas and plasma virus antibodies to Coxsackie B- and reoviruses.
    Tasaka Y; Inoue Y; Marumo K; Mizuno Y; Hirata Y; Akao Y
    Tohoku J Exp Med; 1985 Jun; 146(2):153-62. PubMed ID: 2862717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A morphological and immunohistochemical investigation of endocrine pancreata from obese ob+/ob+ mice.
    Starich GH; Zafirova M; Jablenska R; Petkov P; Lardinois CK
    Acta Histochem; 1991; 90(1):93-101. PubMed ID: 1675542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pancreatic glucagon and C-peptide secretion during hyperinsulinemia in euglycemic glucose clamp with or without somatostatin infusion in normal man.
    Wu MS; Ho LT
    Horm Metab Res; 1987 Jun; 19(6):253-6. PubMed ID: 2887501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia.
    Rastogi KS; Lickley L; Jokay M; Efendic S; Vranic M
    Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to insulin, pancreatic polypeptide, glucagon, and somatostatin in insulin-treated diabetics.
    Fitz-Patrick D; Patel YC
    J Clin Endocrinol Metab; 1981 May; 52(5):948-52. PubMed ID: 6112233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon in spontaneously diabetic KK mice.
    Ohneda A; Kobayashi T; Nihei J; Nishikawa K
    Horm Metab Res; 1981 Apr; 13(4):207-11. PubMed ID: 7016707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of brain-derived neurotrophic factor on pancreatic islets in obese diabetic mice.
    Yamanaka M; Itakura Y; Inoue T; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
    Metabolism; 2006 Oct; 55(10):1286-92. PubMed ID: 16979397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon response to hypoglycemia is improved by insulin-independent restoration of normoglycemia in diabetic rats.
    Shi ZQ; Rastogi KS; Lekas M; Efendic S; Drucker DJ; Vranic M
    Endocrinology; 1996 Aug; 137(8):3193-9. PubMed ID: 8754739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of anterior hypothalamic lesions on neurohypophysial and peripheral tissue concentrations of somatostatin in the rat.
    Patel YC; Hoyte K; Martin JB
    Endocrinology; 1979 Sep; 105(3):712-5. PubMed ID: 467331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor.
    Olchovsky D; Bruno JF; Wood TL; Gelato MC; Leidy JW; Gilbert JM; Berelowitz M
    Endocrinology; 1990 Jan; 126(1):53-61. PubMed ID: 1967164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GI hormonal changes in diabetes influence pancreatic cancer growth.
    Fisher WE; Boros LG; O'Dorisio TM; O'Dorisio MS; Schirmer WJ
    J Surg Res; 1995 Jun; 58(6):754-8. PubMed ID: 7791356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.